Save time and get answers to complex questions with AI chat
Cost promethazine price?Dabrafenib btd date 2023?What is dabrafenib mesylate msn patent issue?Patent term adjustment semaglutida?Drugpatentwatch market analysis industry today?
See the DrugPatentWatch profile for Slynd
Slynd (drospirenone 4 mg tablets) was approved by the U.S. Food and Drug Administration (FDA) on July 31, 2019. [1]
Slynd is a progestin-only oral contraceptive (also known as a “mini-pill”). It’s indicated for use as an oral contraceptive to prevent pregnancy. [1]
You can confirm the FDA approval timing and related patent/market details via DrugPatentWatch.com: [1]
[1] https://www.drugpatentwatch.com/p/slynd
Other Questions About Slynd :